AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 100 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $794,000 | -40.3% | 39,654 | -41.9% | 0.00% | – |
| Q2 2018 | $1,331,000 | +389.3% | 68,250 | +405.5% | 0.00% | – |
| Q1 2018 | $272,000 | -71.6% | 13,501 | -74.1% | 0.00% | – |
| Q2 2017 | $957,000 | -73.8% | 52,037 | -67.8% | 0.00% | -100.0% |
| Q1 2017 | $3,648,000 | +116.1% | 161,739 | +233.5% | 0.00% | – |
| Q4 2016 | $1,688,000 | -84.0% | 48,499 | -74.8% | 0.00% | -100.0% |
| Q1 2015 | $10,529,000 | -0.7% | 192,626 | -22.6% | 0.00% | 0.0% |
| Q4 2014 | $10,606,000 | +1.4% | 248,861 | -24.1% | 0.00% | 0.0% |
| Q3 2014 | $10,464,000 | +54.9% | 327,940 | +0.6% | 0.00% | +50.0% |
| Q2 2014 | $6,756,000 | +19.7% | 326,060 | +11.8% | 0.00% | 0.0% |
| Q1 2014 | $5,645,000 | -32.8% | 291,760 | -15.7% | 0.00% | 0.0% |
| Q4 2013 | $8,401,000 | +23.7% | 346,152 | +9.5% | 0.00% | 0.0% |
| Q3 2013 | $6,793,000 | -13.8% | 316,230 | -10.7% | 0.00% | -33.3% |
| Q2 2013 | $7,881,000 | – | 354,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |